ANGIOTECH PHARMACEUTICALS INC Comprehensive Income
ANGIOTECH PHARMACEUTICALS INC reported Comprehensive Income of -$4.44 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-28.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2013-03-28
- ANGIOTECH PHARMACEUTICALS INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2012-12-31 was $6.23M.
- ANGIOTECH PHARMACEUTICALS INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2012-09-30 was -$7.44M.
- ANGIOTECH PHARMACEUTICALS INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2012-06-30 was -$4.70M.
- ANGIOTECH PHARMACEUTICALS INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2012-03-31 was $1.47M.
- ANGIOTECH PHARMACEUTICALS INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2012 was -$4.44M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 2 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 5 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 8 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|---|---|
| 2012-12-31 | $6.23M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | -$1.21M derived: sum of 2 quarters · filed 2013-03-28 | -$5.91M derived: sum of 3 quarters · filed 2013-03-28 | -$4.44M 10-K · filed 2013-03-28 | |||
| 2012-09-30 | -$7.44M 10-Q · filed 2012-11-14 | -$12.14M derived: sum of 2 quarters · filed 2012-11-14 | -$10.67M 10-Q · filed 2012-11-14 | ||||
| 2012-06-30 | -$4.70M 10-Q/A · filed 2012-09-13 | -$3.23M 10-Q/A · filed 2012-09-13 | |||||
| 2012-03-31 | $1.47M 10-Q · filed 2012-05-15 | ||||||
| 2011-12-31 | -$65.86M 10-K · filed 2013-03-28 | ||||||
| 2011-09-30 | -$22.11M 10-Q · filed 2012-11-14 | -$37.38M 10-Q · filed 2012-11-14 | |||||
| 2011-06-30 | -$15.27M 10-Q/A · filed 2012-09-13 |